Chicken scFvs and bivalent scFv-CH fusions directed against HSP65 of Mycobacterium bovis

Biologicals

Volumn 38, Issue 3, 2010, Pages 407-414

  Wemmer, Susan ^a,b   Mashau, Cordelia ^a   Fehrsen, Jeanni ^a,b   van Wyngaardt, Wouter ^a   du Plessis, Dion H ^a  

^a ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Antibody engineering; Chicken IgY; Gold nanoparticle; Immunoassays; Phage display

Indexed keywords

GOLD NANOPARTICLE; HEAT SHOCK PROTEIN 65; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN Y; POLYSTYRENE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ARTICLE; BOVINE TUBERCULOSIS; CHICKEN; COLLOID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; IMMUNOASSAY; IMMUNOBLOTTING; MYCOBACTERIUM BOVIS; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERODIAGNOSIS;

ANIMALS; BACTERIAL PROTEINS; CATTLE; CHAPERONIN 60; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; MYCOBACTERIUM BOVIS; PEPTIDE LIBRARY; RECOMBINANT FUSION PROTEINS; SENSITIVITY AND SPECIFICITY; SINGLE-CHAIN ANTIBODIES; TUBERCULOSIS, BOVINE;

MYCOBACTERIUM BOVIS;

EID: 77952940259     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2010.02.002     Document Type: Article

References (38)

1. Pollock J.M., Neill S.D. Mycobacterium bovis infection and tuberculosis in cattle. Vet J 2002, 163:115-127.
2. Cousins D.V., Huchzermeyer H.F.K.A., Griffin J.F.T., Brückner G.K., van Rensburg I.B.J., Kriek N.P.J. Tuberculosis. Infectious diseases of livestock 2004, 1973-1993. Oxford, Cape Town. J.A.W. Coetzer, R.C. Tustin (Eds.).
3. Michel A.L., Bengis R.G., Keet D.F., Hofmeyr M., De Klerk L.M., Cross P.C., et al. Wildlife tuberculosis in South African conservation areas: implications and challenges. Vet Microbiol 2006, 112:91-100.
4. Baker M.G., Lopez L.D., Cannon M.C., De Lisle G.W., Collins D.M. Continuing Mycobacterium bovis transmission from animals to humans in New Zealand. Epidemiol Infect 2006, 134:1068-1073.
5. Shinnick T.M., Sweetser D., Thole J., van Embden J., Young R.A. The etiologic agents of leprosy and tuberculosis share an immunoreactive protein antigen with the vaccine strain Mycobacterium bovis BCG. Infect Immun 1987, 55:1932-1935.
6. Whipple D.L., Palmer M.V., Slaughter R.E., Jones S.L. Comparison of purified protein derivatives and effect of skin testing on results of a commercial gamma interferon assay for diagnosis of tuberculosis in cattle. J Vet Diagn Invest 2001, 13:117-122.
7. Hoogenboom H.R., Griffiths A.D., Johnson K.S., Chiswell D.J., Hudson P., Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res 1991, 19:4133-4137.
8. Dübel S. Recombinant therapeutic antibodies. Appl Microbiol Biotechnol 2007, 74:723-729.
9. Reynaud C., Anquez V., Dahan A., Weill J. A single rearrangement event generates most of the chicken immunoglobulin light chain diversity. Cell 1985, 40:283-291.
10. Davies E.L., Smith J.S., Birkett C.R., Manser J.M., Anderson-Dear D.V., Young J.R. Selection of specific phage-display antibodies using libraries derived from chicken immunoglobulin genes. J Immunol Methods 1995, 186:125-135.
11. van Wyngaardt W., Malatji T., Mashau C., Fehrsen J., Jordaan F., Miltiadou D., et al. A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes. BMC Biotechnol 2004, 4. 10.1186/1472-6750-4-6.
12. Muyldermans S. Single domain camel antibodies: current status. Rev Mol Biotechnol 2001, 74:277-302.
13. Nakamura N., Shuyama A., Hojyo S., Shimokawa M., Miyamoto K., Kawashima T., et al. Establishment of a chicken monoclonal antibody panel against mammalian prion protein. J Vet Med Sci 2004, 66:807-814.
14. Fehrsen J., van Wyngaardt W., Mashau C., Potgieter A.C., Chaudhary V.K., Gupta A., et al. Serogroup-reactive and type-specific detection of bluetongue virus antibodies using chicken scFvs in inhibition ELISAs. J Virol Methods 2005, 129:31-39.
15. Finlay W.J.J., Shaw I., Reilly J.P., Kane M. Generation of high-affinity chicken single-chain Fv antibody fragments for measurement of Pseudonitzschia pungens toxin domoic acid. Appl Environ Microbiol 2006, 72:3343-3349.
16. Foord A.J., Muller J.D., Yu M.Y., Wang L., Heine H.G. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC. J Immunol Methods 2007, 321:142-151.
17. Lee Y., Leu S.C., Hung H., Wu H., Huang I., Hsieh W., et al. A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage. Vet Immunol Immunopathol 2007, 117:75-85.
18. Miyamoto K., Shimamoto T., Aosasa M., Kimura S., Nakamura N., Okubo Y., et al. Development of recombinant chicken IgY from single chain fragment variable region for diagnosis of BSE. Biologicals 2007, 35:31-34.
19. Sato Y., Nishimichi N., Nakano A., Takikawa K., Inoue N., Matsuda H., et al. Determination of LOX-1 ligand activity in mouse plasma with a chicken monoclonal antibody for ApoB. Atherosclerosis 2008, 200:303-309.
20. Kolosova A.Y., de Saeger S., Sibanda L., Verheijen R., van Peteghem C. Development of a colloidal gold-based lateral-flow immunoassay for the rapid simultaneous detection of zearalenone and deoxynivalenol. Anal Bioanal Chem 2007, 389:2103-2107.
21. Chiao D., Wey J., Shyu R., Tang S. Monoclonal antibody-based lateral flow assay for the detection of botulinum neurotoxin type A. Hybridoma 2008, 21:31-35.
22. Laderman E.I., Whitworth E., Dumaual E., Jones M., Hudak A., Hogrefe W., et al. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood. Clin Vaccine Immunol 2008, 15:159-163.
23. Posthuma-Trumpie G.A., Kork J., van Amerongen A. Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey. Anal Bioanal Chem 2009, 393:569-582.
24. Greunke K., Spillner E., Braren I., Seismann H., Kainz S., Hahn U., et al. Bivalent monoclonal IgY antibody formats by conversion of recombinant antibody formats. J Biotechnol 2006, 124:446-456.
25. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999, 41:95-98.
26. L interaction of human antibodies. J Biochem 2002, 132:775-782.
27. Evan G.I., Lewis G.K., Ramsay G., Bishop J.M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 1985, 5:3610-3616.
28. Geoghegan W.D., Ackerman G.A. Adsorption of horseradish peroxidase, ovomucoid and anti-immunoglobulin to colloidal gold for the indirect detection of concanavalin A, wheat germ agglutinin and goat anti-human immunoglobulin G on cell surfaces at the electron microscopic level: a new methods, theory and application. J Histochem Cytochem 1977, 25:1187-1200.
29. Shields M.J., Siegel J.N., Clark C.R., Hines K.K., Potempa L.A., Gewurz H., et al. An appraisal of polystyrene- (ELISA) and nitrocellulose-based (ELIFA) enzyme immunoassay systems using monoclonal antibodies reactive toward antigenically distinct forms of human C-reactive protein. J Immunol Methods 1991, 141:253-261.
30. Butler J.E., Navarro P., Sun J. Adsorption-induced antigenic changes and their significance in ELISA and immunological disorders. Immunol Invest 1997, 26:39-54.
31. Dávalos-Panjota L., Ortega-Vinuesa J.L., Bastos-González D., Hidalgo-Álvarez R. Colloidal stability of IgG- and IgY-coated latex microspheres. Colloid Surf B 2001, 20:165-175.
32. de Haard H.J., van Neer N., Reurs A., Hufton S.E., Roovers R.C., Henderikx P., et al. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem 1999, 274:18218-18230.
33. Wörn A., Plückthun A. Stability engineering of antibody single-chain Fv fragments. J Mol Biol 2001, 305:898-1010.
34. Brockmann E., Cooper M., Strömsten N., Vehniäinen M., Saviranta P. Selecting for antibody scFv fragments with improved stability using phage display with denaturation under reducing conditions. J Immunol Methods 2005, 296:159-170.
35. Moutel S., El Marjou A., Vielemeyer O., Nizak C., Benaroch P., Dübel S., et al. A multi-Fc-species system for recombinant antibody production. BMC Biotechnol 2009, 9. 10.1186/1472-6750-9-14.
36. Scallon B., Cai A., Radewonuk J., Naso M. Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency. Mol Immunol 2004, 41:73-80.
37. Di Niro R., Ziller F., Florian F., Crovella S., Stebel M., Bastagno M., et al. Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models. BMC Biotechnol 2007, 7.
38. Quintero-Hernández V., Juárez-González V.R., Ortíz-León M., Sánchez R., Possani L.D., Becerril B. The change of the scFv into the Fab format improves the stability and in vivo toxin neutralization capacity of recombinant antibodies. Mol Immunol 2007, 44:1307-1315.